<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117959/" ref="ordinalpos=274&amp;ncbi_uid=3369810&amp;link_uid=PMC3117959" image-link="/pmc/articles/PMC3117959/figure/F1/" class="imagepopup">Figure 1.  From: Distinct effects of loss of classical estrogen receptor <span class="highlight" style="background-color:">signaling</span> versus complete deletion of estrogen receptor alpha on bone. </a></div><br /><div class="p4l_captionBody">ER signaling pathways. The classical pathway of ERÎ± action (left) requires direct binding to EREs found in the control regions of estradiol (E2)-regulated genes. The non-classical pathway can involve either nuclear (middle) or membrane (right) signaling. In non-classical nuclear signaling, the ER interacts with other transcription factors, such as the jun/fos complex which binds to AP-1 sites, whereas in the membrane pathway, ER signaling is via alterations in kinase activity.</div></div>